Loading
A phase 2 trial of pembrolizumab, fludarabine, cyclophosphamide and aldesleukin (high-dose IL-2) in colorectal cancer, run by National Cancer Institute (NCI), now recruiting.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer is a phase 2, interventional study registered as NCT01174121 by National Cancer Institute (NCI), with a registry enrolment figure of 332 participants, started 2010-08-26 and due to reach its primary completion in 2028-12-27. Interventions recorded: Pembrolizumab (Keytruda); Fludarabine; Cyclophosphamide; Aldesleukin; Young TIL. Conditions listed: Metastatic Colorectal Cancer; Metastatic Pancreatic Cancer; Metastatic Ovarian Cancer; Metastatic Breast Carcinoma; Metastatic Endocrine Tumors/ Neuroendocrine Tumors. Primary outcome: Response rate. Colorectal eligibility wording from the registry: "* Patients with metastatic colorectal cancer must have received oxaliplatin or irinotecan". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Aldesleukin (high-dose IL-2), Fludarabine, Cyclophosphamide, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Fludarabine, Cyclophosphamide, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Pembrolizumab and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Pembrolizumab and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Pembrolizumab and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Pembrolizumab and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Pembrolizumab and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Cytotoxic chemotherapy and the tag colorectal-deep-dive.